Abiopharma

News list

Director Everson Carolyn 🟢 acquired 2.6K shares (1 derivative) of COCA COLA CO (KO) Transaction Date: Apr 01, 2026 | Filing ID: 000109

Full text

News bot April 3, 2026, 5:16 p.m.
🔍 Everson Carolyn (Director)

Company: COCA COLA CO (KO)

Report Date: 2026-04-01
Transaction Summary:
- Total transactions: 2
- Derivative instruments: 1
- Holdings reported: 1
- Total shares acquired: 2,638
- Total shares held: 1,582
Detailed Transactions and Holdings:
- Holds 0 shares of Common Stock, $.25 Par Value (Direct)
  Date: 2026-04-01 | Code: H | shares_owned_after: 1,582.00 | Footnotes: F1
- Acquired 2,638 shares of Phantom Share Units (Derivative)
  Date: 2026-04-01 | Code: A | equity_swap_involved: 0 | shares_owned_after: 14,754.12 | transaction_form_type: 4 | Footnotes: F2, F3, F4, F4, F5
Footnotes:
- F1: Exhibit Index - Exhibit No. 24 - Power of Attorney
- F2: Each phantom share unit is economically equivalent to one share of Common Stock.
- F3: Phantom share units credited to the reporting person under The Coca-Cola Company Directors' Plan effective June 1, 2025 (the "Directors' Plan") for 2026 compensation, which may include voluntary deferred compensation.
- F4: The phantom share units credited under the Directors' Plan are settled in cash the later of (i) January 15 of the year following the year in which the reporting person leaves the Board, or (ii) six months following the date on which the reporting person leaves the Board.
- F5: This number includes phantom share units accrued through April 1, 2026 under the Directors' Plan as a result of crediting phantom dividends.